Cargando…

Incidence and Survival Outcomes of Breast Cancer with Synchronous Hepatic Metastases: A Population-Based Study

Background: Little is known about the clinical features of breast cancer with synchronous hepatic metastases (BCSHM). In this retrospective study, we aimed to feature the incidence and survival outcome of BCSHM. Methods: Data from the 2016 SEER*Stat database (version 8.3.2) was used. The effect of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Weikai, Zheng, Shaoquan, Yang, Anli, Zhang, Xingcai, Liu, Peng, Xie, Xinhua, Tang, Hailin, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277653/ https://www.ncbi.nlm.nih.gov/pubmed/30519334 http://dx.doi.org/10.7150/jca.29190

Ejemplares similares

Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
por: Xiao, Weikai, et al.
Publicado: (2018)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Prognostic value of chronic hepatitis B virus infection in patients with breast cancer in a hepatitis B virus endemic area
por: Xiao, Weikai, et al.
Publicado: (2020)

Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study
por: Xiao, Weikai, et al.
Publicado: (2018)

SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
por: Xiao, Weikai, et al.
Publicado: (2020)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis
por: Zou, Yutian, et al.
Publicado: (2019)

Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A multidimensional analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer
por: Yang, Anli, et al.
Publicado: (2021)

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2022)

Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Correction to: Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

The Impact of Preoperative Radiomics Signature on the Survival of Breast Cancer Patients With Residual Tumors After NAC
por: Zhang, Ling, et al.
Publicado: (2021)

Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Melatonin Regulates Breast Cancer Progression by the lnc010561/miR-30/FKBP3 Axis
por: Liu, Peng, et al.
Publicado: (2019)

The biogenesis, function and clinical significance of circular RNAs in breast cancer
por: Zeng, Yan, et al.
Publicado: (2022)

Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study
por: Yu, Ping, et al.
Publicado: (2020)

Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies
por: Ye, Feng, et al.
Publicado: (2020)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

Hepatitis B virus infection specially increases risk of liver metastasis in breast cancer patients: a propensity-matched analysis
por: Yu, Ping, et al.
Publicado: (2020)

circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
por: Ye, Feng, et al.
Publicado: (2019)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
por: Zou, Yutian, et al.
Publicado: (2022)

Diagnostic and prognostic value of circular RNA CDR1as/ciRS‐7 for solid tumours: A systematic review and meta‐analysis
por: Zou, Yutian, et al.
Publicado: (2020)

BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer
por: Jiao, Shiping, et al.
Publicado: (2014)

Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer
por: Xie, Xinhua, et al.
Publicado: (2019)

Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study
por: Lurvink, Robin J., et al.
Publicado: (2021)

Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study
por: Zheng, Shaoquan, et al.
Publicado: (2023)

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
por: Tian, Wenwen, et al.
Publicado: (2023)

Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study
por: Zhao, Hai-yun, et al.
Publicado: (2018)

MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
por: Ye, Feng, et al.
Publicado: (2014)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022)

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer
por: Wang, Jin, et al.
Publicado: (2017)

Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population
por: Lin, Shaoyan, et al.
Publicado: (2021)

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
por: Liu, Peng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_98ceiqess11ugbvj9o03pi9ftk